# AMADEUS (NCT04173533)

> Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04173533
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: University of Birmingham
- Conditions: Acute Myeloid Leukemia; Myelodysplasia
- Interventions: Oral azacitidine; Matched placebo
- Enrollment: 326
- Primary outcome: Relapse free survival (RFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- YouTube: 8
- Podcasts: 6
- X threads: 2
- Bluesky threads: 2

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=amadeus-nct04173533

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04173533", "email": "<work email>"}; the inbox owner confirms by the emailed link.